Skip to main content
. 2020 Dec 10;11:606274. doi: 10.3389/fgene.2020.606274

FIGURE 4.

FIGURE 4

MiR-26a low plasma levels correlate with adverse outcome. Kaplan– Meier and log-rank analysis for overall survival (OS) (A) and progression-free survival (PFS) (B) were performed for the cohort of RMS patients (n = 22) based on low or high miR-26a plasma levels (median value). The group of patients with lower miR-26a plasma levels displays a significantly poor outcome (OS, P = 0.033; PFS, P = 0.028).